2nd Quarter - Termination
ERVIN GRAVES STRATEGY GROUP, LLC for RARE ACCESS ACTION PROJECT
Client
Income
$10,000
Expenses
—
Terminated
Jun 30, 2023
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Advice and counsel related to funding for matters related to rare disease research and treatmen
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT SALMON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.